Literature DB >> 9370291

Isolation of human and mouse HMG2a cDNAs: evidence for an HMG2a-specific 3' untranslated region.

K Wilke1, S Wiemann, R Gaul, W Gong, A Poustka.   

Abstract

We have isolated cDNAs of the human gene for high mobility group protein HMG2a, using the method of direct cDNA selection. The gene maps to chromosome band Xq28, and is located within 40 kb from marker DXS1684, at a distance of 5.4 Mb from the telomere. The deduced human HMG2a protein sequence has a length of 199 amino acids and is 97% identical to the sequence of chicken HMG2a. The 3' untranslated regions of the HMG2a gene in both species are highly homologous (87% identical nucleotides), and are even more conserved than the coding sequences (84% identical nucleotides). In addition, a partial cDNA sequence of the putative HMG2a gene from mouse was identified. The 3' untranslated regions from human and mouse are 90% identical. We conclude that the 3' untranslated sequences have been under strong selective pressure during evolution. Whereas expression of the chicken HMG2a gene has previously been demonstrated in liver of newly hatched chicken, the human HMG2a gene is transcribed mainly in placenta.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9370291     DOI: 10.1016/s0378-1119(97)00324-7

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  3 in total

Review 1.  The role of high mobility group protein B3 (HMGB3) in tumor proliferation and drug resistance.

Authors:  Bin Wen; Ying-Ting Wei; Kui Zhao
Journal:  Mol Cell Biochem       Date:  2021-01-11       Impact factor: 3.396

Review 2.  High Mobility Group B Proteins, Their Partners, and Other Redox Sensors in Ovarian and Prostate Cancer.

Authors:  Aida Barreiro-Alonso; Mónica Lamas-Maceiras; Esther Rodríguez-Belmonte; Ángel Vizoso-Vázquez; María Quindós; M Esperanza Cerdán
Journal:  Oxid Med Cell Longev       Date:  2015-11-23       Impact factor: 6.543

3.  HMGB3 promotes PARP inhibitor resistance through interacting with PARP1 in ovarian cancer.

Authors:  Hanlin Ma; Gonghua Qi; Fang Han; Wei Lu; Jiali Peng; Rongrong Li; Shi Yan; Cunzhong Yuan; Beihua Kong
Journal:  Cell Death Dis       Date:  2022-03-24       Impact factor: 8.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.